A NEW screening for spinal muscular atrophy (SMA) is now being offered, included in the heel prick test, to all newborns in ...

Spinal muscular atrophy (SMA) is a rare, genetic condition that, across all types, affects ~1,600 people in the UK.1 It can cause muscle weakness which gets worse over time, causing movement, ...

Mother of boy (4), who underwent surgery for condition, says she would not wish her family’s experience ‘on worst enemy’ ...

Panelists discuss how the current spinal muscular atrophy (SMA) treatment landscape includes 3 options: gene therapy (onasemnogene abeparvovec [Zolgensma]) for younger patients and 2 splice modifiers ...

The heel prick test will screen for two more rare conditions from today, the Department of Health has said. It said testing ...

Ashley Webb, MD, Program Director, Pediatric Neurology, at the University of Texas Health Science Center at Houston McGovern Medical School, discusses the need to make genetic therapy more accessible ...

Regina Trollmann, MD, of the Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany, and colleagues, did a retrospective ...

A NEW screening test for two rare genetic conditions is now being offered to all newborn babies in Ireland, the Department of Health has confirmed. The heel-prick test will now also screen for ...

(SMA) causes progressive muscle weakness and, without treatment, can limit life expectancy to just two years. The milestone means the petition, to include SMA in post-birth baby checks for serious ...

The local unit of US biotech major Biogen today announced that the UK’s Medicines and Healthcare Products Regulatory Agency ...

A number of babies have already been tested under the expanded programme.

Forbes contributors publish independent expert analyses and insights. Spinal muscular atrophy affects the nerves that control muscle movement, leading to progressive weakening. As a result, infants ...